Hamada A, Nakano M, Shimidzu S, Hasegawa T, Kawaguchi T
Department of Pharmacy, Kumamoto University Hospital, Japan.
Biol Pharm Bull. 1997 Aug;20(8):935-8. doi: 10.1248/bpb.20.935.
The inhibitory effect of acyclothymidine[AcyT, 5-methyl-1-(2'-hydroxyethoxymethyl) uracil], a potent pyrimidine nucleoside phosphorylase (PyNPase) inhibitor, on 5'-deoxy-5-fluorouridine (5'-DFUR) phosphorolysis in human and mouse tumor cell homogenates was measured. Competitive inhibition was observed in MKN-74 and Lewis lung carcinoma (LLC), whereas non-competitive inhibition was observed in HeLa. The strength of the inhibitory effect by AcyT showed the following pattern: HeLa < human normal intestine < mouse normal intestine < Colon 26 < LLC < MKN-74 < DLD-1. From the kinetic parameter obtained, we simulated the inhibitory effect of AcyT on 5'-DFUR phosphorolysis in tumor cells and the intestine. These data indicated that AcyT was more sensitive in normal mouse intestine than in Colon 26 and LLC, and that orally administered AcyT can reduce the intestinal toxicity of 5'-DFUR without reducing the antitumor effect in the mouse. The present finding may have an important implication for attempts to introduce AcyT, a potent PyNPase inhibitor, into the clinic.
测定了强效嘧啶核苷磷酸化酶(PyNPase)抑制剂阿昔胸腺嘧啶核苷[AcyT,5-甲基-1-(2'-羟基乙氧基甲基)尿嘧啶]对人和小鼠肿瘤细胞匀浆中5'-脱氧-5-氟尿苷(5'-DFUR)磷酸解的抑制作用。在MKN-74和Lewis肺癌(LLC)中观察到竞争性抑制,而在HeLa细胞中观察到非竞争性抑制。AcyT的抑制作用强度呈现以下模式:HeLa < 人正常肠道 < 小鼠正常肠道 < 结肠26 < LLC < MKN-74 < DLD-1。根据获得的动力学参数,我们模拟了AcyT对肿瘤细胞和肠道中5'-DFUR磷酸解的抑制作用。这些数据表明,AcyT在正常小鼠肠道中比在结肠26和LLC中更敏感,口服AcyT可以降低5'-DFUR的肠道毒性,而不降低其对小鼠的抗肿瘤作用。目前的发现可能对将强效PyNPase抑制剂AcyT引入临床的尝试具有重要意义。